Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.
Jacobio Pharmaceuticals is a pharmaceutical company, which engages in the development of drugs.
Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.
Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.
Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.
Brisbane, US HQ
St. Louis, US
Tongzhou, CN HQ
Dublin, IE HQ
Saint Louis, FR
Lyon, FR HQ
San Carlos, US HQ
Alexa Website Rank
Alexa Website Rank501168
Alexa Website Rank666585
Alexa Website Rank146118
Alexa Website RankN/A
Alexa Website Rank523742
Latest funding round
Latest funding round$ 105m (over 1 year ago)
Latest funding round$ 55m (about 4 years ago)
Latest funding round$ 35.5m (almost 2 years ago)
Latest funding round$ 2.5m (over 2 years ago)
Latest funding round$ 65m (over 2 years ago)
Total funding raised
Total funding raised$ 155m
Total funding raised$ 55m
Total funding raised$ 35.5m
Total funding raised$ 6.8m
Total funding raised$ 158m